Literature DB >> 6976356

Production of antibodies specific for Fc, Fab', and streptokinase-streptodornase in vitro by peripheral blood cells from patients with rheumatoid arthritis and normal donors. Identification of immune complexes in culture supernatants containing hidden antibodies reactive with Fab' fragments of immunoglobulin G.

H H Birdsall, R D Rossen.   

Abstract

To study antibody (Ab) biosynthesis in rheumatoid arthritis (RA), the immunoglobulin (Ig)M anti-Fc, anti-Fab', and antistreptokinase-streptodornase (SKSD) produced by peripheral blood lymphocytes (PBL) were measured at intervals from 1 to 19 d in culture. PBL from 17 seropositive patients with active RA and 30 age-matched controls were evaluated. Within the first 24 h, PBL from six of eight patients released >30 ng IgM anti-Fc, even in the absence of pokeweed mitogen (PWM). This early release of Ab was blocked by cycloheximide. With or without PWM, PBL from normal donors did not release IgM anti-Fc until after 3-5 d in vitro. By day 9, unstimulated PBL from seven patients made > 100 ng IgM anti-Fc. Un-stimulated PBL from normals never made >95 ng of this Ab. When PWM was added, PBL from normal donors released as much IgM anti-Fc as was found in RA donor cultures. Paradoxically, addition of PWM to PBL of RA patients suppressed release of IgM anti-Fc in 4 of 17 cases to levels significantly below those found in unstimulated cultures of the same cells. Without PWM, PBL from RA donors frequently failed to make IgM anti-SKSD (P < 0.05 compared with normal donors' cells). With PWM, the quantities of IgM anti-SKSD released were comparable. Fluctuations in IgM anti-Fab' levels during the life-time of these cultures were sufficient to suggest that these Ab may be taken up in immune complexes. This hypothesis was verified by acidifying (pH 3.1) culture supernatants to which (125)I-Fab' had been added previously. The samples were then neutralized (pH 7.6) and 12% polyethylene glycol was added to separate free from antibody-bound (125)I-Fab'. This procedure increased the quantity of (125)I-Fab' precipitated by > 10-fold in some cases. These studies suggest that there are a variety of abnormalities in Ab biosynthesis in RA. These include spontaneous synthesis of comparatively large quantities of IgM anti-Fc, relatively suppressed release of IgM anti-SKSD, and a paradoxical reduction, in some cases, in the biosynthesis of IgM anti-Fc after addition of PWM.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6976356      PMCID: PMC371170          DOI: 10.1172/jci110443

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  An antigen-binding capacity test for human immunoglobulin G (IgG) fragments.

Authors:  J C Cerottini
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

3.  [Method of preparation of beta-macroglobulin from human serum].

Authors:  R Masseyeff; J Gombert; J Josselin
Journal:  Immunochemistry       Date:  1965-06

4.  In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults.

Authors:  W J Koopman; R E Schrohenloher
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

5.  Correlation of gm allotype with the incidience of anti-IgG antibody in coal workers' pneumoconiosis.

Authors:  M S Mentnech; D J Pearson; J A Elliott; G Taylor; P C Major
Journal:  Clin Immunol Immunopathol       Date:  1980-10

6.  Distribution of rheumatoid factor activity in nonrheumatoid states.

Authors:  H Bartfeld
Journal:  Ann N Y Acad Sci       Date:  1969-12-10       Impact factor: 5.691

7.  Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG.

Authors:  D A Carson; S Lawrance; M A Catalano; J H Vaughan; G Abraham
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

8.  Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

9.  HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production.

Authors:  J H Dobloug; O Førre; E Kåss; E Thorsby
Journal:  Arthritis Rheum       Date:  1980-03

10.  CELLULAR ORIGIN OF RHEUMATOID FACTOR.

Authors:  R C Mellors; R Heimer; J Corcos; L Korngold
Journal:  J Exp Med       Date:  1959-11-30       Impact factor: 14.307

View more
  6 in total

1.  Immunoglobulin secretion in human disease states.

Authors:  M G Beale; R P MacDermott
Journal:  Surv Immunol Res       Date:  1983

2.  Acute rheumatoid factor positive (IgM) polyarthritis associated with a Klebsiella pneumonitis.

Authors:  M Magaro'; L Altomonte; A Zoli; L Mirone; M C Berchicci
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

3.  IgG binding of monoclonal anti-nuclear antibodies from MRL-lpr/lpr mice.

Authors:  D S Pisetsky; B S Darwin; C F Reich
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

4.  Demonstration of anti-idiotypic antibodies directed against IgM rheumatoid factor in the serum of rheumatoid arthritis patients.

Authors:  W K Hancock; E V Barnett
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

5.  Induction of an anti-Fab, anti-DNA and anti-RNA polymerase I autoantibody response network in rabbits immunized with SLE anti-DNA antibody.

Authors:  E Rombach; D A Stetler; J C Brown
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

6.  Spontaneous immunoglobulin synthesis by peripheral mononuclear cells in active rheumatoid arthritis.

Authors:  G Doekes; M L Westedt; H H de Rooy-Dijk; M R Daha; E de Vries; A Cats
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.